Volanesorsen (Ionis Pharmaceuticals) is an antisense oligonucleotide that inhibits hepatic synthesis of ApoC3 and used for the treatment of familial chylomicronemia syndrome, familial partial lipodystrophy, and hypertriglyceridemia. This evidence concerns the gene APOC3 and familial chylomicronemia syndrome.